SMAD2 and non-small cell lung carcinoma: We observed an interaction between SMAD2 and miRNAs, such that SMAD2 expression was suppressed by the direct binding of miR-486-5p to the 3' UTR of SMAD2, providing a new insight into developing a therapeutic strategy for NSCLC.